Why BlackBerry, AeroVironment, and Global Blood Therapeutics Slumped on Wednesday
Find out how earnings hurt some of these stocks.
3 Top E-Commerce Stocks to Buy Right Now
Investors have some good reasons to consider Stitch Fix, Alibaba, and Zillow as stock buys today.
Brookfield Infrastructure Partners in 3 Charts
These three charts should help investors quickly get up to speed on the global infrastructure giant.
The e-commerce titan aims to take it up another notch with its fifth annual sales event.
A Congressman wants to remove an exception that makes brands like Facebook possible.
The company took a less traditional path to being traded.
A high-profile analyst questioned the company's recent FDA approval.
Amazon Wins ‘.amazon’ Domain Name, Aggravating South American Region and Undermining Digital Commons
Who has the right to use an Amazon domain name? The people who live there or a company with the same name? ICANN has sold out the Brazilians.
The Fed gave the market what it was expecting; PayPal, not so much.
Investors are increasingly optimistic about the company.
Much like gold prices, the gold miner is on the up-and-up.
There's still room for growth in the business -- but in the stock price? Not so fast.
Disney and Comcast opened this year's two most anticipated attractions in recent weeks. One nailed it, but the other got nailed.
After a weak start to the fiscal year, the supermarket chain still thinks it can meet its modest growth objectives.
Just 0.7% of Spotify subscribers bill through the App Store.
The investment data specialist is seeing a lot of growth.
Stocks lost ground on Tuesday morning.
Investors are cheering Allergan and jeering AbbVie after the announcement of a major acquisition.
Here's how these biotech stocks became the biggest on the market -- and how their future prospects look.
A downgrade from Credit Suisse torpedoed the annuities seller.
Investors in their later years might want to give these income payers a closer look.
The home video release of "Captain Marvel" illustrates why a third player may be the ultimate victor in the battle between the streaming market leader and Disney+ later this year.
Overpaying for Allergan would be a serious misstep.